scholarly journals Differential Scanning Calorimetry, as a New Method to Monitor Human Plasma in Melanoma Patients with Regional Lymph Node or Distal Metastases

10.5772/25606 ◽  
2011 ◽  
Author(s):  
Andrea Ferencz ◽  
Tamas Fekecs ◽  
Denes Lorinczy
Keyword(s):  
Differential Scanning Calorimetry ◽  
Lymph Node ◽  
Human Plasma ◽  
Regional Lymph Node ◽  
New Method ◽  
Scanning Calorimetry ◽  
Melanoma Patients

scholarly journals Melanoma Inhibitory Activity and regional lymph node status in malignant melanoma patients

2015 ◽  
Vol 13 (Suppl 1) ◽  
pp. P11
Author(s):  
Angela Sandru ◽  
Silviu Voinea ◽  
Eugenia Panaitescu ◽  
Madalina Bolovan ◽  
Adina Stanciu ◽  
...  
Keyword(s):  
Lymph Node ◽  
Malignant Melanoma ◽  
Inhibitory Activity ◽  
Regional Lymph Node ◽  
Lymph Node Status ◽  
Node Status ◽  
Melanoma Inhibitory Activity ◽  
Melanoma Patients

Differential scanning calorimetry (DSC) analysis of human plasma in different psoriasis stages

2012 ◽  
Vol 111 (3) ◽  
pp. 1801-1804 ◽  
Author(s):  
Moezzi Mehdi ◽  
Tamás Fekecs ◽  
István Zapf ◽  
Andrea Ferencz ◽  
Dénes Lőrinczy
Keyword(s):  
Differential Scanning Calorimetry ◽  
Human Plasma ◽  
Dsc Analysis ◽  
Scanning Calorimetry

Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: Results of an intergroup randomized trial (ANZMTG 01.02/TROG 02.01)

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. LBA9084-LBA9084
Author(s):  
M. A. Henderson ◽  
B. Burmeister ◽  
J. F. Thompson ◽  
J. Di Iulio ◽  
R. Fisher ◽  
...  
Keyword(s):  
Lymph Node ◽  
Randomized Trial ◽  
Annual Meeting ◽  
Clinical Oncology ◽  
Adjuvant Radiotherapy ◽  
Regional Lymph Node ◽  
Field Control ◽  
Melanoma Patients ◽  
Final Text ◽  
Financial Relationships

LBA9084 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. No significant financial relationships to disclose.

scholarly journals 1099 Financial Implications of Implementing MSLT-II Trial Findings for Treatment of Cutaneous Malignant Melanoma Patients in A Tertiary Referral Centre in The United Kingdom

2021 ◽  
Vol 108 (Supplement_6) ◽  
Author(s):  
A T Misky ◽  
A H Sadr ◽  
D Nikkhah
Keyword(s):  
United Kingdom ◽  
Lymph Node ◽  
Malignant Melanoma ◽  
Regional Lymph Node ◽  
Financial Burden ◽  
Cutaneous Malignant Melanoma ◽  
Inpatient Stay ◽  
The United Kingdom ◽  
Melanoma Patients ◽  
The Cost

Abstract Aim Cutaneous malignant melanoma is a significant public health challenge in the United Kingdom. Since the new American Joint Committee on Cancer (AJCC) version 8 definition of melanoma staging, more melanoma patients are eligible for sentinel lymph node biopsies (SLNB). Prior to the MSLT-II trial, SLNB positive patients were treated as a distinct group within cutaneous melanoma patients and in most centres would routinely undergo lymph node clearance (LNC) of the regional lymph node basin to control disease. Given the above developments in melanoma care, we compared the cost of SLNB and monitoring to the cost of LNC for patients with melanoma. Method We retrospectively reviewed all SLNB positive patients undergoing LNC or surveillance in 2019. We measured the cost of all clinical encounters for both groups and performed a cost analysis. Results Our study shows that the mean cost per patient of axillary LNC is £4731.64 and groin LNC is £5381.78 against a cost of £2896.67 for SLNBs. Mean inpatient stay was 2.8 nights following LNC and 0.11 nights following SLNB. 50% of LNCs and 11% of SLNBs were associated with post-operative complications. Conclusions Our data shows that treating uncomplicated SLNB positive patients with surveillance rather than immediate LNC results in reduced morbidity, lower complication rate and shorter inpatient stay for the patients, as well as lower financial burden to the unit. This is reflected by the UK Consensus statement on melanoma, suggesting that LNC should not be routinely offered for positive SLNB without high-risk features.

Analysis of T cell receptor β and γ genes from peripheral blood, regional lymph node and tumor-infiltrating lymphocyte clones from melanoma patients

1991 ◽  
Vol 32 (5) ◽  
pp. 325-330 ◽  
Author(s):  
Mark R. Albertini ◽  
Janice A. Nicklas ◽  
Bettejayne F. Chastenay ◽  
Timothy C. Hunter ◽  
Richard J. Albertini ◽  
...  
Keyword(s):  
Lymph Node ◽  
T Cell ◽  
T Cell Receptor ◽  
Peripheral Blood ◽  
Regional Lymph Node ◽  
Cell Receptor ◽  
Tumor Infiltrating Lymphocyte ◽  
Melanoma Patients
Sign in / Sign up

Export Citation Format

Share Document